Additionally, the current study showed that in rats with GN-induced ARF, our treatment regimens, which include solo LS, GSH, and their combination in both NP formulations, significantly reduced serum cystatin C levels and renal tissue concentrations of NGAL and KIM-1, indicating a linked improvement in ARF. This evidence concerns the gene CST3 and ganglioneuroma.